Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033859 · ClinicalTrials.gov registry record
Incidence of Bleeding on Probing as an Indicator of Peri-Implant Disease Progression
A clinical trial, sponsored by University of Pittsburgh.
- Active
- Registry status
- 164
- Enrollment target
NCT06033859 is a clinical trial that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 164 participants.
The verdict
NCT06033859 is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 164 participants
- Enrollment target
Study Summary
The primary goal of the present prospective cohort study is to evaluate the effect of varying incidences of BOP at implant sites across 15 months of maintenance visits on the probability of peri-implant disease progression. Over 15 months, participants will attend 6 visits where clinical measurements and maintenance care will be performed every 3 months.
Interventions
- DIAGNOSTIC_TEST Clinical measurements
- DIAGNOSTIC_TEST Radiographic measurement
- PROCEDURE Dental prophylaxis or maintenance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06033859
The ClinicalTrials.gov registry entry for NCT06033859 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Clinical measurements is the first listed.
NCT06033859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06033859 about?
NCT06033859 is a clinical study titled "Incidence of Bleeding on Probing as an Indicator of Peri-Implant Disease Progression". The primary goal of the present prospective cohort study is to evaluate the effect of varying incidences of BOP at implant sites across 15 months of maintenance visits on the probability of peri-implant disease progression. Over 15 months, participants will attend 6 visits where clinical measurement...
What is the current status of trial NCT06033859?
This trial is currently active not recruiting. The enrollment target is 164 participants. The study started on 2023-09-11. Estimated completion is 2027-12.
What interventions are being tested in trial NCT06033859?
The interventions under investigation include: Clinical measurements (DIAGNOSTIC_TEST), Radiographic measurement (DIAGNOSTIC_TEST), Dental prophylaxis or maintenance (PROCEDURE).
Who is sponsoring clinical trial NCT06033859?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.